375 Expansion of HPV-16 specific T cells in patients with HPV-related cancers treated with bintrafusp alfa

by Jeffrey Schlom, James Gulley, Caroline Jochems, Renee Donahue, Samuel Pellom, Julius Strauss, Nicole Toney, Yo-Ting Tsai, Claire Rumfield
Published 2020-11-01

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells

by Yvette Robbins, Sarah Greene, Jay Friedman, Paul E Clavijo, Carter Van Waes, Kellsye P Fabian, Michelle R Padget, Houssein Abdul Sater, John H Lee, Patrick Soon-Shiong, James Gulley, Jeffrey Schlom, James W Hodge, Clint T Allen
Published 2020-07-01

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab

by Elaine M. Jagoda PhD, Olga Vasalatiy PhD, Falguni Basuli PhD, Ana Christina L. Opina PhD, Mark R. Williams BS, Karen Wong MS, Kelly C. Lane BS, Steve Adler PhD, Anita Thein Ton MS, Lawrence P. Szajek PhD, Biying Xu PhD, Donna Butcher BS, Elijah F. Edmondson DVM, PhD, Rolf E. Swenson PhD, John Greiner PhD, James Gulley MD, PhD, Janet Eary MD, Peter L. Choyke MD
Published 2019-04-01